Clinics in Dermatology
Volume 27, Issue 3, Supplement , Pages S13-S22 , May 2009

Skin augmentation and correction: the new generation of dermal fillers—A dermatologist's experience

References 

  1. Werschler WP. Treating the aging face: a multi-disciplinary approach with calcium hydroxylapatite and other fillers, part 1. Cosmet Dermatol. 2007;20:739–742
  2. Donofrio LM. Fat distribution: a morphologic study of the aging face. Dermatol Surg. 2000;26:1107–1112
  3. Donofrio LM. Structural autologous lipoaugmentation: a pan-facial technique. Dermatol Surg. 2000;26:1129–1134
  4. Wang F, Garza LA, Kang S, et al. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol. 2007;143:155–163
  5. Simamora P, Chern W. Poly-L-lactic acid: an overview. J Drugs Dermatol. 2006;5:436–440
  6. Keni SP, Sidle DM. Sculptra (injectable poly-L-lactic acid). Facial Plast Surg Clin North Am. 2007;15:91–97
  7. Valantin MA, Aubron-Olivier C, Ghosn J, et al. Polylactic acid implants (New-Fill®) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS. 2003;17:2471–2477
  8. Moyle GJ, Lysakova L, Brown S, et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med. 2004;5:82–87
  9. Sherman RN. Sculptra: the new three-dimensional filler. Clin Plast Surg. 2006;33:539–550
  10. Gogolewski S, Jovanovic M, Perren SM, et al. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate (PHB/VA). J Biomed Mater Res. 1993;27:1135–1148
  11. Lombardi T, Samson J, Plantier F, et al. Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study of 11 cases. J Oral Pathol Med. 2004;33:115–120
  12. Vleggaar D. Soft-tissue augmentation and the role of poly-L-lactic acid. Plast Reconstr Surg. 2006;118(suppl):46S–54S
  13. Sculptra prescribing information. Bridgewater, NJ: Dermik Laboratories. http://products.sanofi-aventis.us/sculptra/sculptra.html. Accessed Oct 17, 2008.
  14. Hamilton TK, Dhar AD, Duong NT. A study comparing the efficacy of injectable poly-L-lactic acid reconstituted at 24 hours to injection versus 3 weeks prior to injection [Filler and Injectable abstract session]. In: Presented at the American Society for Dermatologic Surgery–American College of Mohs Micrographic Surgery and Cutaneous Oncology Combined Annual Meeting; Atlanta, Georgia; Oct 27-30. 2005;
  15. Woerle B, Hanke CW, Sattler G. Poly-L-lactic acid: temporary filler for soft tissue augmentation. J Drugs Dermatol. 2004;3:385–389
  16. Ahn MS. Calcium hydroxylapatite: Radiesse. Facial Plast Surg Clin North Am. 2007;15:85–90
  17. Gravier MH, Bass LS, Busso M, et al. Calcium hydroxylapatite (Radiesse) for correction of the mid- and lower face: consensus recommendations. Plast Reconstr Surg. 2007;120(suppl 6):55S–66S
  18. Tzikas TL. Evaluation of the Radiance FN soft tissue filler for facial soft tissue augmentation. Arch Facial Plast Surg. 2004;6:234–239
  19. Johl SS, Burgett RA. Dermal filler agents: a practical review. Curr Opin Ophthalmol. 2006;17:471–479
  20. Berlin A, Cohen JL, Goldberg DJ. Calcium hydroxylapatite for facial rejuvenation. Semin Cutan Med Surg. 2006;25:132–137
  21. Murray CA, Zloty D, Warshawski L. The evolution of soft tissue fillers in clinical practice. Dermatol Clin. 2005;23:343–363
  22. Felderman LI. Radiesse™ for facial rejuvenation. Cosmetic Dermatol. 2005;18:823–826
  23. Busso M, Karlsberg PL. Cheek augmentation and rejuvenation using injectable calcium hydroxylapatite (Radiesse®). Cosmet Dermatol. 2006;19:583–588
  24. Goldberg DJ. Calcium hydroxylapatite. In:  Goldberg DJ editors. Fillers in cosmetic dermatology. Abingdon, UK: Informa UK, Ltd; 2006;p. 81–109
  25. Jansen DA, Graivier MH. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation. Plast Reconstr Surg. 2006;118(suppl 3):22S–30Sdiscussion 31S-33S
  26. Radiesse home page. http://www.radiesse.comAccessed Sep 18, 2008
  27. Radiesse® injectable implant instructions for use. http://www.radiesseusa.com/pdf/Radiesse_IFU.pdfAccessed Sep 18, 2008
  28. Busso M, Applebaum D. Hand augmentation with Radiesse (calcium hydroxylapatite). Dermatol Ther. 2007;20:385–387
  29. Busso M, Voigts R. An investigation of changes in physician properties of injectable calcium hydroxylapatite in a carrier gel when mixed with lidocaine and with lidocaine/epinephrine. Dermatol Surg. 2008;34(suppl 1):S16–S24
  30. Alam M, Yoo SS. Technique for calcium hydroxylapatite injection for correction of nasolabial fold depressions. J Am Acad Dermatol. 2007;56:285–289
  31. Pessa JE, Zadoo VP, Mutimer KL, et al. Relative maxillary retrusion as a natural consequence of aging: combining skeletal and soft-tissue changes into an integrated model of midfacial aging. Plast Reconstr Surg. 1998;102:205–212
  32. Werschler WP. Advanced injection techniques of poly-L-lactic acid: a case-based presentation. Dermatol Ther. 2007;20(suppl 1):S16–S19
  33. Sadick NS, Katz BE, Roy D. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face. Dermatol Surg. 2007;33(suppl 2):S122–S126
  34. Smith S, Busso M, McClaren M, Bass LS. A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human-based collagen for the correction of nasolabial folds. Dermatol Surg. 2007;33(suppl 2):S112–S121
  35. Moers-Carpi M, Tufet JO. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled split-face trial. Dermatol Surg. 2008;34:210–215
  36. Moers-Carpi M, Vogt S, Santos BM, et al. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg. 2007;33(suppl 2):S144–S151
  37. Roy D, Mangat DS. Facial implants. Dermatol Clin. 2005;23:541–547
  38. Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler complications. Plast Reconstr Surg. 2006;118(suppl 3):92S–107S
  39. Glavas IP. Filling agents. Ophthalmol Clin North Am. 2005;18:249–257
  40. Hamilton T. Glabella, forehead, and temple. [CS155 Fillers session] In: Oral presentation at the American Society for Dermatologic Surgery Annual Meeting; Chicago, Illinois; Oct 11-14. 2007;

PII: S0738-081X(08)00250-2

doi: 10.1016/j.clindermatol.2008.12.001

Clinics in Dermatology
Volume 27, Issue 3, Supplement , Pages S13-S22 , May 2009

Article Tools

* Image Usage & Resolution